Coffee intake in midlife and risk of dementia and its neuropathologic correlates

Journal of Alzheimer's Disease

Volumn 23, Issue 4, 2011, Pages 607-615

  Gelber, Rebecca P ^a   Petrovitch, Helen ^a   Masaki, Kamal H ^a   Ross, G Webster ^a   White, Lon R ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Caffeine; coffee; cohort studies; dementia

Indexed keywords

ARTICLE; BRAIN REGION; COFFEE; COGNITIVE DEFECT; COLA; DEMENTIA; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; RISK FACTOR; TEA;

EID: 79953269390     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-101428     Document Type: Article

References (29)

1. Cao C, Cirrito JR, Lin X, Wang L, Verges DK, Dickson A, Mamcarz M, Zhang C, Mori T, Arendash GW, Holtzman DM, Potter H (2009) Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. J Alzheimers Dis 17, 681-697.
2. Arendash GW, Mori T, Cao C, Mamcarz M, Runfeldt M, Dickson A, Rezai-Zadeh K, Tane J, Citron BA, Lin X, Echeverria V, Potter H (2009) Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. J Alzheimers Dis 17, 661-680.
3. Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J (2006) Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience 142, 941-952. (Pubitemid 44740473)
4. Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M (2009) Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis 16, 85-91.
5. Laitala VS, Kaprio J, Koskenvuo M, Raiha I, Rinne JO, Silventoinen K (2009) Coffee drinking in middle age is not associated with cognitive performance in old age. Am J Clin Nutr 90, 640-646.
6. Syme SL, Marmot MG, Kagan A, Kato H, Rhoads G (1975) Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: intro-duction. Am J Epidemiol 102, 477-480.
7. White L, Petrovitch H, Ross GW, Masaki KH, Abbott RD, Teng EL, Rodriguez BL, Blanchette PL, Havlik RJ, Wergowske G, Chiu D, Foley DJ, Murdaugh C, Curb JD (1996) Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. JAMA 276, 955-960. (Pubitemid 26318224)
8. Teng EL, Hasegawa K, Homma A, Imai Y, Larson E, Graves A, Sugimoto K, Yamaguchi T, Sasaki H, Chiu D, et al. (1994) The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 6, 45-58; discussion 62. (Pubitemid 24167129)
9. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, third edition, revised, American Psychiatric Association, Washington, DC
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's dis-ease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
11. Petrovitch H, White LR, Ross GW, Steinhorn SC, Li CY, Masaki KH, Davis DG, Nelson J, Hardman J, Curb JD, Blanchette PL, Launer LJ, Yano K, Markesbery WR (2001) Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology 57, 226-234. (Pubitemid 32667355)
12. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R (1992) Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 42, 473-480.
13. Abbott RD, White LR, Ross GW, Masaki KH, Curb JD, Petrovitch H (2004) Walking and dementia in physically capa-ble elderly men. JAMA 292, 1447-1453. (Pubitemid 39258337)
14. White L (2009) Brain lesions at autopsy in older Japanese-American men as related to cognitive impairment and dementia in the final years of life: a summary report from the Honolulu-Asia aging study. J Alzheimers Dis 18, 713-725.
15. Petrovitch H, Ross GW, Steinhorn SC, Abbott RD, Markesbery W, Davis D, Nelson J, Hardman J, Masaki K, Vogt MR, Launer L, White LR (2005) AD lesions and infarcts in demented and non-demented Japanese-American men. Ann Neurol 57, 98-103. (Pubitemid 40053320)
16. Hankin JH, Nomura A, Rhoads GG (1975) Dietary patterns among men of Japanese ancestry in Hawaii. Cancer Res 35, 3259-3264.
17. McGee D, Rhoads G, Hankin J, Yano K, Tillotson J (1982) Within-person variability of nutrient intake in a group of Hawaiian men of Japanese ancestry. Am J Clin Nutr 36, 657-663. (Pubitemid 13223056)
18. Lopez-Garcia E, Rodriguez-Artalejo F, Rexrode KM, Logroscino G, Hu FB, van Dam RM (2009) Coffee con-sumption and risk of stroke in women. Circulation 119, 1116-1123.
19. Taaffe DR, Irie F, Masaki KH, Abbott RD, Petrovitch H, Ross GW, White LR (2008) Physical activity, physical func-tion, and incident dementiain elderly men: the Honolulu-Asia Aging Study. J Gerontol A Biol Sci Med Sci 63, 529-535.
20. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31, 545-548. (Pubitemid 20107994)
21. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51, 83-133. (Pubitemid 29113867)
22. Ritchie K, Artero S, Portet F, Brickman A, Muraskin J, Beanino E, Ancelin ML, Carriere I (2010) Caffeine, cognitive functioning, and white matter lesions in the elderly: establish-ing causality from epidemiological evidence. J Alzheimers Dis20 (Suppl 1), S161-S166.
23. Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung KH, Tanner CM, Masaki KH, Blanchette PL, Curb JD, Popper JS, White LR (2000) Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 283, 2674-2679 (Pubitemid 30337329)
24. Prediger RD (2010)Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms. J Alzheimers Dis 20 (Suppl 1), S205-S220.
25. Santos C, Costa J, Santos J, Vaz-Carneiro A, Lunet N (2010) Caffeine intake and dementia: systematic review and meta-analysis. J Alzheimers Dis 20 (Suppl 1), S187-S204.
26. Maia L, de Mendonca A (2002) Does caffeine intake protect from Alzheimer's disease? Eur J Neurol 9, 377-382. (Pubitemid 35013893)
27. Ritchie K, Carriere I, de Mendonca A, Portet F, Dartigues JF, Rouaud O, Barberger-Gateau P, Ancelin ML (2007) The neuroprotective effects of caffeine: a prospective pop-ulation study (the Three City Study). Neurology 69, 536-545. (Pubitemid 47357260)
28. Santos C, Lunet N, Azevedo A, de Mendonca A, Ritchie K, Barros H (2010) Caffeine intake is associated with a lower risk of cognitive decline: a cohort study from Portugal. J Alzheimers Dtis 20 (Suppl 1), S175-S185.
29. de Mendonca A, Cunha RA (2010) Putative neuroprotective effects of caffeine in clinical trials. Concluding remarks. J Alzheimers Dis 20 (Suppl 1), S249-S252.